信號轉(zhuǎn)導(dǎo)與靶向治療(ISSN 2059-3635 (online)， ISSN 2095-9907 (print)， CN 51-1758/R)是一份開放獲取的期刊，旨在及時發(fā)表與信號轉(zhuǎn)導(dǎo)和靶向治療相關(guān)的基礎(chǔ)科學(xué)和臨床研究的最新發(fā)現(xiàn)和進展。它將包括對主要人類疾病的研究，如癌癥、自身免疫性疾病等。

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others.